Lymphocyte subsets ACT

ACT

Immunology

CD38 is a marker of early activation and in studies has been shown to be useful in monitoring HIV patients starting to fail therapy prior to observing decreased CD4 counts. DR (MHC II) is a useful marker of activation. MHC II deficient SCIDs may be CD4 lymphopaenic

0.5 mls EDTA

Samples should be less than 24 hours old and arrive before 2pm on a Friday. A full blood count MUST be taken the same day to allow enumeration and full evaluation of lymphocytes

4 days

Not applicable

Yes